Catalog name Description price
R-Mcs-353 HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Succinyl Fluorescent Lipid Rhodamine lipid (headgroup) HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Succinyl(57:38:4:1molar ratio) Fluorescent Lipid Rhodamine lipid (headgroup) can be used for tumor drug delivery, active targeted therapy (such as folate receptor targeting), and treatment imaging integration. price>
R-Mcs-354 HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio)Fluorescent Lipid DiA HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio)Fluorescent Lipid DiA for drug delivery or bio-imaging . This liposomal formulation could be used in various research and therapeutic contexts, such as: Drug Delivery: The combination of PEGylation and cholesterol increases stability, while the fluorescent DiA tag enables visual tracking of drug delivery in vivo or in vitro. Bio-Imaging: The fluorescent properties of DiA allow for real-time visualization of liposome movement, uptake by cells, and distribution in tissues. Targeting Studies: The cyanur-modified DSPE-PEG could allow for the attachment of ligands (like antibodies or small molecules) that target specific cell surface receptors, enhancing the selectivity of liposomal drug delivery systems. price>
R-Mcs-355 HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid DiD HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid DiD is a liposomal formulation combining lipid components with fluorescent tagging to enable drug delivery and bio-imaging. Drug Delivery: This liposomal system can be used to encapsulate therapeutic agents, improving their stability, bioavailability, and targeted delivery to specific cells or tissues. Fluorescence Imaging: DiD serves as a fluorescent marker to visualize the movement and distribution of liposomes in vivo, aiding in the study of biodistribution and pharmacokinetics. Targeted Therapy: The cyanur-modified DSPE-PEG(2000) allows for conjugation with targeting molecules, such as antibodies or peptides, for specific targeting of diseased tissues, such as tumors. price>
R-Mcs-356 HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid DiI HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid DiI is a liposomal formulation combining lipid components with fluorescent tagging to enable drug delivery and bio-imaging. Drug Delivery: This liposomal system can be used to encapsulate therapeutic agents, improving their stability, bioavailability, and targeted delivery to specific cells or tissues. Fluorescence Imaging:DiI serves as a fluorescent marker to visualize the movement and distribution of liposomes in vivo, aiding in the study of biodistribution and pharmacokinetics. Targeted Therapy:The cyanur-modified DSPE-PEG(2000) allows for conjugation with targeting molecules, such as antibodies or peptides, for specific targeting of diseased tissues, such as tumors. price>
R-Mcs-357 HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid DiO HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid DiO is a liposomal formulation combining lipid components with fluorescent tagging to enable drug delivery and bio-imaging. Drug Delivery: This liposomal system can be used to encapsulate therapeutic agents, improving their stability, bioavailability, and targeted delivery to specific cells or tissues. Fluorescence Imaging:DiO serves as a fluorescent marker to visualize the movement and distribution of liposomes in vivo, aiding in the study of biodistribution and pharmacokinetics. Targeted Therapy:The cyanur-modified DSPE-PEG(2000) allows for conjugation with targeting molecules, such as antibodies or peptides, for specific targeting of diseased tissues, such as tumors. price>
R-Mcs-358 HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid DiR HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid DiR is a liposomal formulation combining lipid components with fluorescent tagging to enable drug delivery and bio-imaging. Drug Delivery: This liposomal system can be used to encapsulate therapeutic agents, improving their stability, bioavailability, and targeted delivery to specific cells or tissues. Fluorescence Imaging:DiR serves as a fluorescent marker to visualize the movement and distribution of liposomes in vivo, aiding in the study of biodistribution and pharmacokinetics. Targeted Therapy:The cyanur-modified DSPE-PEG(2000) allows for conjugation with targeting molecules, such as antibodies or peptides, for specific targeting of diseased tissues, such as tumors. price>
R-Mcs-359 HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur Fluorescent Lipid Dansyl lipid (head group) HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid Dansyl lipid (head group) is a PEGylated liposomal formulation incorporating a headgroup-labeled fluorescent lipid (Dansyl) for membrane tracking, surface labeling, or targeting studies. It is designed for use in drug delivery, membrane interaction assays, and bioimaging. price>
R-Mcs-360 HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur Fluorescent Lipid NBD lipid (fatty acid tail) HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid NBD lipid (fatty acid tail) for drug delivery, fusion, and biophysical membrane interaction studies. price>
R-Mcs-361 HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur Fluorescent Lipid NBD lipid (headgroup) HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid NBD lipid (headgroup) for drug delivery, fusion, and biophysical membrane interaction studies. price>
R-Mcs-362 HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur Fluorescent Lipid Pyrene lipid (headgroup) HSPC:Chol:DSPE-PEG(2000):DSPE-PEG(2000)-Cyanur(57:38:4:1molar ratio) Fluorescent Lipid Pyrene lipid (headgroup) for drug delivery, fusion, and biophysical membrane interaction studies. price>